Liver Cirrhosis Market Size
Market Size in USD Bn
CAGR5.4%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 5.4% |
| Market Concentration | High |
| Major Players | Madrigal Pharmaceuticals, Inc., Galectin Therapeutics Inc., Grifols Therapeutics LLC, CymaBay Therapeutics, Akero Therapeutics, Inc. and Among Others |
please let us know !
Liver Cirrhosis Market Analysis
The Global liver cirrhosis market is estimated to be valued at USD 1.49 Billion in 2025 and is expected to reach USD 2.15 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032. The increasing prevalence of liver diseases and rising alcohol consumption globally are major factors contributing to the growth of liver cirrhosis cases.
Key factors such as the rising geriatric population, growing awareness about liver cirrhosis treatment and management, new product approvals, and improving healthcare infrastructure in developing nations are expected to contribute to the market growth during the forecast period. However, the high cost of treatment and lack of effective diagnosis and treatment in developing countries are some challenges restraining the market growth.